winthrop products inc. vs eupharma laboratories ltd. on 2 september, 1997

11
Bombay High Court Bombay High Court Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997 Author: A Sakhare Bench: A Sakhare ORDER A.Y. Sakhare, J. 1. By this motion, plaintiffs are seeking order of injunction against defendants from using in any form or manner trade mark or name PANADOL and/or from passing off or attempting to pass off defendants' product in the name of PANADOL. Plaintiffs' claim is based upon infringement of trade mark and passing off. 2. Plaintiffs are corporation organised and governed by the State of Dalaware and has its head office at U.S.A. Plaintiffs are manufacturer of drugs and pharmaceuticals including an Antipyretic and Analgesic drugs, which is marketed by plaintiff on the trade mark PANADOL, a word mark invented by plaintiffs. 3. Plaintiffs claim to be the proprietor of trade mark PANADOL, which has been registered by plaintiffs in several countries across the world. Plaintiffs sell the said drug in several countries. Plaintiffs have started using this trade mark since about 1955. As per plaintiffs, said trade mark PANADOL is internationally famous mark and has acquired an extensive and valuable goodwill. Plaintiffs' annual global sales of 1994 off PANADOL was 240 million U.S. Dollers. The drug marketed under the trade mark PANADOL is an antipyretic and analgesic and is sold across the counter. 4. As per plaintiffs, word PANADOL was invented by plaintiff's predecessor in or about 1955. On 9-6-1955, a circular was issued to the staff of the plaintiffs' predecessor inviting suggestions of a short name for a new analgesic product. After suggestions were received, seven names were shortlisted. Plaintiff finally adopted PANADOL as trade mark with TRIMON as a reserve. Plaintiffs have placed reliance upon circular dated 9-6-1955, internal date on shortlisted trade mark including PANADOL, internal memo dated 27-4-1956, internal memo dated 10-10-1956 relating to questionnaire on PANADOL. Plaintiffs have also placed upon Hospital Price List of February 1968, circular dated 8-11-196 8. National Health Service Dispensing Doctors' Price List dated 1-2-1968, Dispensing Doctors' Price List of January 1969, Hospital Price List of January 1970, Dispensing Doctors' Price List of January 1970, circular on price change dated 16-7-1970 and Price List of 1971. On this material, plaintiffs claim that its product is marketed under trade mark PANADOL right from 1955 or thereabout and is sold across various countries. Plaintiffs have also placed reliance upon several medical journals published between 1956 to 1962. The s aid journals are British Medical J ournal, the Lancet Journal, the Pharmaceutical Journal, the Chemist and Druggist Journal, the Irish Chemist, Druggist Journal and the Chemist and Druggist Year Book to show that plaintiffs have used this trade mark for its product and said trade mark has a worldwide recognition. 5. On 21-10-1982, plaintiffs were registered as proprietor of the trade mark PANADOL in India under Clause 5 of IV Schedule to the Trade and Merchandise Marks Act (hereinafter referred to as the 'Act' for the sake of brevity) under No. 396820. Plaintiffs have received intimation of such registration in or about February 1995. As per plaintiffs, when its application for registration was in process, on 13-1-1992, notice of opposition was filed by the predecessor of defendant to oppose the registration of the aforesaid trade mark. The said opposition was on the basis of its alleged use of the trade mark PANADOL by defendant since 1972. In notice of opposition, defendants filed interlocutory petition, which was dismissed by the Deputy Registrar and plaintiffs were granted registration. Defendants have challenged the order passed by the Deputy Registrar by filing F.A.O. No. 187 of 1993 before Delhi High Court. The said appeal is still pending without any interim orders in defendant's favour. Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997 Indian Kanoon - http://indiankanoon.org/doc/774606/ 1

Upload: rajesuresh

Post on 14-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 1/11

Bombay High Court

Bombay High Court

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Author: A Sakhare

Bench: A Sakhare

ORDER

A.Y. Sakhare, J.

1. By this motion, plaintiffs are seeking order of injunction against defendants from using in any form or

manner trade mark or name PANADOL and/or from passing off or attempting to pass off defendants' product

in the name of PANADOL. Plaintiffs' claim is based upon infringement of trade mark and passing off.

2. Plaintiffs are corporation organised and governed by the State of Dalaware and has its head office at U.S.A.

Plaintiffs are manufacturer of drugs and pharmaceuticals including an Antipyretic and Analgesic drugs, which

is marketed by plaintiff on the trade mark PANADOL, a word mark invented by plaintiffs.

3. Plaintiffs claim to be the proprietor of trade mark PANADOL, which has been registered by plaintiffs in

several countries across the world. Plaintiffs sell the said drug in several countries. Plaintiffs have startedusing this trade mark since about 1955. As per plaintiffs, said trade mark PANADOL is internationally

famous mark and has acquired an extensive and valuable goodwill. Plaintiffs' annual global sales of 1994 off 

PANADOL was 240 million U.S. Dollers. The drug marketed under the trade mark PANADOL is an

antipyretic and analgesic and is sold across the counter.

4. As per plaintiffs, word PANADOL was invented by plaintiff's predecessor in or about 1955. On 9-6-1955, a

circular was issued to the staff of the plaintiffs' predecessor inviting suggestions of a short name for a new

analgesic product. After suggestions were received, seven names were shortlisted. Plaintiff finally adopted

PANADOL as trade mark with TRIMON as a reserve. Plaintiffs have placed reliance upon circular dated

9-6-1955, internal date on shortlisted trade mark including PANADOL, internal memo dated 27-4-1956,

internal memo dated 10-10-1956 relating to questionnaire on PANADOL. Plaintiffs have also placed uponHospital Price List of February 1968, circular dated 8-11-1968. National Health Service Dispensing Doctors'

Price List dated 1-2-1968, Dispensing Doctors' Price List of January 1969, Hospital Price List of January

1970, Dispensing Doctors' Price List of January 1970, circular on price change dated 16-7-1970 and Price List

of 1971. On this material, plaintiffs claim that its product is marketed under trade mark PANADOL right from

1955 or thereabout and is sold across various countries. Plaintiffs have also placed reliance upon several

medical journals published between 1956 to 1962. The said journals are British Medical Journal, the Lancet

Journal, the Pharmaceutical Journal, the Chemist and Druggist Journal, the Irish Chemist, Druggist Journal

and the Chemist and Druggist Year Book to show that plaintiffs have used this trade mark for its product and

said trade mark has a worldwide recognition.

5. On 21-10-1982, plaintiffs were registered as proprietor of the trade mark PANADOL in India under Clause

5 of IV Schedule to the Trade and Merchandise Marks Act (hereinafter referred to as the 'Act' for the sake of 

brevity) under No. 396820. Plaintiffs have received intimation of such registration in or about February 1995.

As per plaintiffs, when its application for registration was in process, on 13-1-1992, notice of opposition was

filed by the predecessor of defendant to oppose the registration of the aforesaid trade mark. The said

opposition was on the basis of its alleged use of the trade mark PANADOL by defendant since 1972. In notice

of opposition, defendants filed interlocutory petition, which was dismissed by the Deputy Registrar and

plaintiffs were granted registration. Defendants have challenged the order passed by the Deputy Registrar by

filing F.A.O. No. 187 of 1993 before Delhi High Court. The said appeal is still pending without any interim

orders in defendant's favour.

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 1

Page 2: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 2/11

6. As per plaintiff, on 7-2-1971, predecessor of defendants applied for registration of trade mark PADADOL

for its user. At that time concerned authority pointed out to the defendants' predecessor that the trade mark of 

similar name has been registered by other party. In view of this objection of the authority, defendants'

predecessor abandoned its application but started using name PANADOL for its product from year 1972. As

per plaintiffs, the said act of defendants is dishonest, as defendants were aware that the authority concerned

has rejected its request and that defendant has abandoned its claim for word PANADOL. After plaintiffs'

application for registration, defendants have applied for registration of same trade mark and said application is

still pending. As per the record, notice of opposition is filed by plaintiffs. Plaintiffs have filed this suit on theaverments that in March 1995, defendants came with share issue, wherein one of the product referred to was

PANADOL. As per plaintiffs, at this time it got knowledge about the user by defendants. The plaintiffs have

filed this suit on the ground of infringement of trade mark and on passing off.

7. Defendants have registered the claim on the ground that in year 1963, defendants, predecessor in title as a

sole proprietor started company in the name of Eupharma Laboratories and started its production. In year

1971, the said proprietory concern was converted in partnership firm under the name M/s. Eupharma

Laboratories. In years 1972, defendants started manufacturing an analgesic pharmaceutical product under the

trade mark PANADOL. In year 1985, a private limited company was incorporated by name Eupharma

Laboratories Pvt. Ltd. As per defendants, partnership was dissolved and its assets and goodwill along with

tenancy rights, licenses, trade marks, patents design etc. were taken over by private limited company. In year1982, said private limited company became a Public Limited Company under the provisions of Companies

Act, 1956.

8. As per defendants, word PANADOL was adopted in year 1971 and used since 1972. Relevant statements in

defendants' affidavit dated 11-4-1997 are as under :

"I say that the word PANADOL was adopted in 1971 and used since 1972 by the Defendants'

predecessor-in-title and by the present Defendants. The prefix PAN or PANA often occurs in medical

dictionaries such as Butterworth's Medical Dictionary for various medical terms, for example, "panacea"

which means a universal remedy or a cure-all. The suffix "Dol" in the mark was taken from the prefix "Dol"

occurring in the medical term "DOLOR" which means "physical pain, mental anguish and painful here etc.".In 1971 M/s. Eupharma Laboratories the predecessors-in-title of the Defendants obtained permission from the

Controller of Drugs, State of Maharashtra, for manufacturing medicinal and pharmaceutical preparations

under the trade mark "PANADOL". The food and drugs administration Maharashtra State Bombay granted.

Licence No. 55 on 5th April, 1971 to M/s. Eupharama Laboratories Partnership firm consisting of (1) R. V.

SHAH, (2) B. R. SHAH and (3) Smt. S. R. SHAH. The said drug license was renewed from time to time."

9. As per defendants, it is manufacturing and marketing its product in the name of PANADOL and it has

vested rights for user of the same. Defendants claim that plaintiffs are not operating in India and that

defendants are only using said word PANADOL. As per defendant, out of its total turnover, 3% is turnover

from pharmaceutical product marketed under the name of PANADOL. Defendants have resisted this motion

on the ground that it has vested rights, trade mark is not used in India by plaintiffs, plaintiffs' registration is

not valid as rectification proceedings are pending, adoption of word PANADOL in 1971 was not bad faith,

that plaintiffs are unable to point out instances of confusion or deception and plaintiffs have approached the

Court at very late stage, or plaintiffs have acquiesced with defendants' user of the word PANADOL for its

marketing.

10. On behalf of plaintiffs, it is contended that in year 1955 word PANADOL was invented by plaintiffs'

predecessor. Under this trade mark pharmaceutical product is marketed. Now the said product is marketed in

nearly 98 countries. All important medical journals right from 1956 are referring to plaintiffs' product

PANADOL, even-though, plaintiffs are not marketing its product in India, in view of its international

registration drug being pharmaceutical drug, in law Plaintiffs will be entitled for injunction. That application

made by defendants' predecessor for registration of trade mark was abandoned in year 1971, in spite of this

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 2

Page 3: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 3/11

abandonment defendants have started using word PANADOL to market its of this abandonment defendants

have started using work PANADOL to market its product. This act is dishonest and that as plaintiffs being

registered holder of trade mark PANADOL in India defendants are not entitled to use the trade mark 

PANADOL. Thus, plaintiffs have based its claim on infringement of their mark and on passing off. In support

of these submissions plaintiffs have relied upon several decisions of this Court, Delhi High Court and

Supreme Court. These decisions are

(1) Misc. Petition No. 2 of 1992 Marion Merrell Dow Inc. v. Unichem Laboratories Ltd. decided by Mr.Justice S. N. Variava on 27th April 1994.

(2) Kamal Trading Co. v. Gillette U.K. Limited ((1988) IPLR, 135 (Div. B. of this Court)).

(3) Hindustan Pencils Pvt. Ltd. v. India Stationary Products Co. and another .

(4) Schering Corporation and others v. Kilitch Co. (Pharma) Pvt. Ltd. (Division Bench of this Court) ((1994)

IPLR 1).

(5) National Chemicals & Colour Co. and others v. Reckitt & Colman of India Limited and another .

(6) Ruston & Hornby Ltd. v. Zamindara Engineering Co. .

(7) Poddar Tyres Ltd. v. Bedrock Sales Corporation Ltd. and another .

11. As per defendants, in view of Section 33 of the Act defendants have vested rights, as from 1972 the said

product is manufactured and marketed by defendants as proprietor and user is continuous. Hence no

injunction can be granted in plaintiffs' favour. Plaintiffs' registration is not valid as defendants have filed

rectification application, therefore, plaintiff cannot press their claim on the ground that they have registered

trade mark as PANADOL in India, defendant claims the user as bona fide user and not in bad faith, that there

is no confusion or deception in the customers as plaintiffs are not using trade mark in India, that plaintiffs are

not entitled for injunction in view of delay and as no steps are taken by plaintiffs from year 1971. Defendantshave placed reliance upon

(1) M/s. Radhakishan Narayandas v. Trilokchand and others .

(2) Hindustan Pencils Pvt. Ltd. v. Aptudet Industries (Decision of Delhi High Court Dated 10-7-1991).

(3) R. J. Reynolds Tobacco Co. v. I.T.C. Limited (1986-87 IPLR 180).

(4) Consolidated Foods Corporation v. Brandon & Co. Pvt. Ltd. (1966 B.L.R. 612).

(5) Decision of Calcutta High Court in Appeal No. 530 of 1992 decided on 27/28 September 1993 in case of 

Kabushiki K. Toshiba v. Toshiba Appliance and others.

12. From the facts narrated above, it is clear that plaintiffs have invented word 'PANADOL' in year 1955. In

year 1956 the said trade mark is registered. As on today, the said trade mark is registered by plaintiffs in 98

countries. The said trade mark is also registered in India on 21-1-1982. Defendants' objection for its

registration was overruled. Thus, plaintiffs are holder of registered trade mark PANADOL. Plaintiffs' product

is referred and given wide publicity in all important medical journals. Plaintiffs' trade mark PANADOL is

internationally famous mark and has acquired valuable publicity as a mark used by plaintiffs. It is true that

said product is not sold in India, however, considering law on this point even-though, plaintiffs are not

marketing this product in India in view of drug being pharmaceutical and sold across the counter, plaintiffs

have statutory right to claim injunction against defendant. Reference can be made to two decisions of this

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 3

Page 4: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 4/11

Court in (1) Marion Merrell Dow Inc. v. Unichem Laboratories Ltd., and (2) Kamal Trading Co., and others v.

Gillette U.K. Limited. In Marion Merrell's case, this court has dealt with somewhat similar situation. Relevant

observations in the said decision are as under :

"A person who blatantly copies some body else's mark can have no right in that mark and cannot be said to be

the proprietor thereof. Therefore, once it is shown that the person has no proprietary rights. Then even though

the word is an invented word, the Applicant cannot apply for registration under Section 18(1). Thus, Section 9

must necessarily be read with Section 18(1) and it is only if two are satisfied that the mark can be registered."

"In this behalf it is pertinent to note that as shown by International Bibliography voluminous literature on

Sucralfate has been existing for a number of years. Not only that but in 1982 there was International

Sucralfate Symposium in the 7th World Congress of Gastroenterology at Stockholm. Prior to that in June

1980 there was the 11th International Congress of Gast roenterology at Hamburg wherein the effect of 

Sucralfate on ulcer has been discussed. Not only that in October 1981 there is an article on Petitioners' product

"CARAFATE" as it being an anti-ulcer drug. The 1st Respondents are a medicinal company. It is impossible

to believe that they were not aware of the developments in the use of Sucralfate as an anti-ulcer drug and the

invention of drug "CARAFATE" by the petitioners as an anti-ulcer drug. In my view, it is too much of a

co-incidence that the exact mark and the same preparation for treatment of duodenal ulcers has been suddenly

thought of by the 1st Respondent. As stated above a drug or a medicine is not something which can just bethought of. It needs years research and development. It is very clear that the 1st Respondents have done no

research and/or development in respect of this drug. It has not been claimed, before the Trade Mark Registry

as well as before this Court, that any research was done. No proof of any research or development has been

produced. It would therefore, be clear that the 1st Respondents have not developed this drug but merely

copied it. They could only have learnt about it from international magazines or seminars. If the drug is copied,

it follows that this mark is also copied. In the international market only the Petitioners own the mark 

"CARAFATE" for an anti-ulcer drug. It is, thus, clear that it is the Petitioners' mark and product which has

been copied by the 1st Respondents."

"Further in my view, whilst considering the possibility of likelihood of deception or confusion, in present

times and particularly in the field of medicines, the Courts must also keep in mind the fact that nowadays thefield of medicine is of an international character. The court has to keep in mind the possibility that with the

passage of time, some conflict may occur between the use of the mark by the Applicant in India and the

advertisement and the user by the overseas company. The Court must ensure that public interest is in no way

imperiled. The 2nd Respondent has totality ignored this aspect."

"I am unable to accept the submissions of Mr. Tulzapurkar. All the authorities relied by Mr. Tulzapurkar very

significantly do not deal with the medical field. As already stated above and as set out in the various

authorities relied upon by Mr. Chitnis, the medical field has assumed an international character. It is a fact of 

which judicial notice must be taken. Doctors particulars eminent Doctors, medical practitioners and persons or

companies connected with the medical field keep abreast of latest developments in medicine and preparation

worldwide. Medical literature is freely available in this country. Doctors, medical practitioners and persons

connected with medical field regularly attend medical conferences, symposiums, lectures, etc. Also as set out

hereinabove, what is involved is public interest. It would be anomalous situation if an identical mark in

respect of an identical drug is associated all over the world with the petitioner but that mark remains of the

registered ownership of the 1st Respondents in India. Such a situation would cause immense confusion and

deception in the minds of the public. Also as stated above the authority of the Supreme Court in the case of 

National Sewing Thread Co. Ltd. is binding on this Court and prevails over all contrary authorities of Foreign

Courts."

"In case like this, where the mark is in respect of a field which is of an international character and it is clear

that if the mark is allowed to be registered there will be confusion and deception the question of the petitioner

first establishing reputation in India does not arise. As set out earlier in U.S.A. and Australia the Petitioners'

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 4

Page 5: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 5/11

mark "CARAFATE" was registered prior to the application by the 1st Respondents. It has been registered in

U.S.A. since 26th May, 1981 and in Australia since 7th May, 1982. They have given their sales figures. In

1982 they were in the region of US $ 14 million. The International Bibliography is titled "CARAFATE

Sucralfate". It contains information about numerous discussions, articles, seminars, conferences, etc. Most of 

these are prior to the date of Application by the 1st Respondents. On internal Pg. 1918 it sets out Petitioners'

product "CARAFATE". It shows that this is available since October 1981. It is impossible to believe that in

the filed of medicine, Doctors, medical practitioners and others connected with it would not know of the

Petitioners' mark. This is also established by the questionnaire.

13. In Kamal Trading case, this Court has considered the fact of non-availability of the product in India and

has held that even though, the product is not available in India the proprietor of trade mark, which is of 

international repute will be entitled for injunction. Relevant observations are as under :

"Mr. Tulzapurkar very rightly submitted that the trade mark '7 O'Clock' had acquired worldwide reputation

and any customer purchasing the goods with that mark would immediately connect the goods to the house of 

Gillette which are the registered owners of the mark '7 O'Clock'. It cannot be overlooked that it is not

necessary for the plaintiffs to establish that in fact any customer was deceived, but it is enough if it is shown

that there is likelihood of deception. We have no hesitation in concluding that the user of the mark '7 O'clock'

by the defendants would clearly result in deceiving the customer with the impression that the tooth brushescome from the house of Gillette. A faint submission was advanced by Mr. Desai that the plaintiffs cannot use

trade mark '7 O'clock' simpliciter in India and it is not necessary to add a word 'EJTEK' while selling the razor

blades. We fail to appreciate how additional word would make any difference and how it will enable the

defendants to pass off their products by using the park '7 O'clock' simpliciter."

"We must express our dissent with the view taken in this case. In our judgment, it is not possible to conclude

that the goodwill or the reputation stands extinguished merely because the goods are not available in the

country for some duration. It is necessary to note that the goodwill is not limited to a particular country

because in the present days, the trade is spread all over the world and the goods are transported from one

country to another very rapidly and on extensive scale. The goodwill acquired by the manufacturer is not

necessarily limited to the country where the goods are freely available because the goods though not availableare widely advertised in newspapers, periodicals, magazines and in other medias. The result is that though the

goods are not available in the country, the goods and the mark under which they are sold acquires wide

reputation. Take for example, the television, and video Cassette Recorders manufactured by National, Sony or

other well-known Japanese Concerns. There televisions and V.C.Rs. are not imported in India and sold in

open market because of trade restrictions, but is it possible even to suggest that the word 'National' or 'Sony'

has not acquired reputations in this country ? In our judgment, the goodwill or reputation of goods or marks

does not depend upon its availability in a particular country. It is possible that the manufacturer may suspend

their business activities in a country for short duration but that fact would not destroy the reputation or

goodwill acquired by the manufacturers. An identical view was taken by Division Bench of Mr. Justice S. K.

Desai and Mr. Justice Barucha in a judgment dated July 24, 1986 in Appeal No. 368 of 1986. The question for

consideration before the Division Bench was whether the goodwill in the trade mark "7 O'clock" stood

extinguished because of non-availability of blades with the mark in India after year 1958. The Division Bench

turned down the claim by pointing out various reasons and we are in entire agreement with the observations

made in the judgment on this aspect. In our judgment, it is not possible to follow the view taken in the case of 

'Budweiser'.

14. Considering the decisions of this court referred to above, PANADOL being pharmaceutical product and

plaintiffs being proprietor of this trade mark will be entitled to prevent defendant from using the said trade

mark even in India. Plaintiffs have also registered this trade mark in India in 1982, that too by overruling

defendants' objection. Defendants' appeal is pending before Delhi High Court without any interim orders.

Thus, in law defendants will not be entitled to use trade mark PANADOL to market its product. In my

 judgment, defendants, marketing its product under the name PANADOL is clear infringement of statutory

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 5

Page 6: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 6/11

rights available to plaintiffs, therefore, plaintiffs will be entitled for injunction. Even otherwise under

Common Law Rights as the product being invented by plaintiffs in 1955 and registered nearly in 98 countries

including India, plaintiffs will be entitled to prevent defendants under the Common Law Rights of passing off.

15. At this stage, defendants' case that defendants have vested rights to use the said trade mark will have to be

considered because defendants have placed reliance upon Section 33 of the Act. As per this section, if 

defendants are able to establish bona fide user of trade mark PANADOL for its product from 1972 then no

injunction can be granted against defendants. Much will depend upon finding as to whether defendants' userright from 1972 is bona fide and honest. In year 1955, the word PANADOL was invented by plaintiffs'

predecessor and came to be registered subsequently. The said trade mark is registered by plaintiffs in nearly

98 countries. Thus, plaintiffs have acquired goodwill in respect of the said trade mark through out the world.

The medical magazines referred to above also show that plaintiffs have advertised their product in various

medical magazines of international repute. There show that persons concerned with the medical profession

were aware about the said trade mark and product marketed by plaintiffs under the said trade mark. Medical

literature is freely available through out the world including India. Doctors, practitioners and person

connected with medical field regularly attend medical conferences, symposium, lectures etc. Plaintiffs

company is registered in U.S.A. and plaintiffs' product is registered in several countries such as Australia,

Behrein, Bangladesh, Canada, Denmark, France, Greece, Hongkong, Indonesia, Iraq to name few. There is

tourist traffic across these countries and tourists visit India. Thus, defendants' case of its ignorance about userof plaintiffs company cannot be accepted. In year 1971, first time attempt was made by defendants'

predecessor to register PANADOL trade mark for its product, however, the said application was abandoned

when the objection was raised by the authority that word PANADOL is reserved for some other company and

registration of word PANADOL by defendant will not be permissible. Instead of prosecuting the said

application, defendants abandoned the said application and started marketing its products under mark 

PANADOL. Thus, in year 1972 itself defendant was aware that said word PANADOL is a trade mark 

reserved by other company and in India authorities have refused to grant registration of the said word

PANADOL for defendants' product. User of the word PANADOL in spite of knowledge cannot be termed as

honest user. The said user must be treated as dishonest user and trying to take advantage of goodwill earned

by trade mark PANADOL Defendants are marketing its product under mark PANADOL and customers may

receive the same under the bona fide belief that the said product is that of plaintiffs. Plaintiffs have inventedword PANADOL in year 1955, from year 1956, product is manufactured and marketed under trade mark 

PANADOL. Throughout world, plaintiffs have acquired goodwill as it is registered in nearly 98 countries and

available mostly throughout world. Explanation given by defendants as to how they started using said word

cannot be accepted as the said word was invented by plaintiffs in year 1955 and by 1972 the said words has

acquired considerable goodwill being plaintiffs' product throughout the world. Defendants' Explanation as

referred to above is afterthought. Defendants cannot show ignorance nor any attempt is made to show that

defendants are unaware about the user of this name by plaintiffs. In year 1983, it is plaintiffs who applied first

for registration in India, who succeeded in getting registered its trade mark, while defendants' application for

registration is still pending. Defendants' rectification proceedings are also pending. In these circumstances, I

have no hesitation to come to the conclusion that user of word PANADOL by defendants from year 1972 is

dishonest user, therefore, defendant will not get any protection of Section 33 of the Act.

16. Now, the question which is to be considered about the laches or acquiescence on the part of plaintiffs.

Plaintiffs have claimed that plaintiffs came to know about the user in March 1995. Even-though, this

explanation is not proper as law stands today delay would not defeat plaintiffs' rights. Reliance place by

plaintiffs on decisions of Apex Court, this Court and Delhi High Court to contend that delay cannot defeat

their right to seek injunction will have to be accepted. Apex Court in cases of Ruston & Hornby Ltd. v.

Zamindara Engineering Co., (supra) as observed as under :

"5. But in an infringement action the issue is as follows :

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 6

Page 7: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 7/11

"Is the defendant using a mark which is the same as or which is a colourable imitation of the plaintiffs'

registered trade mark ?"

It very often happens that although the defendant is not using the trade mark of the plaintiff, the get-up of the

defendant's goods may be so much like the plaintiff's that a clear case of passing off would be proved. It is on

the contrary conceivable that although the defendant may be using the plaintiff's mark the get-up of the

defendant's good may be so different from the get-up of the plaintiff's goods and the prices also may be so

different that there would be no probability of deception of the public. Nevertheless, in an action on the trademark, that is to say, in an infringement action, an injunction would issued as soon as i t is proved that the

defendants is improperly using the plaintiff's mark.

6. The action for infringement is a statutory right. It is dependent upon the validity of the registration and

subject to other restrictions laid down in Sections 30, 34 and 35 of the Act. On the other hand the gist of a

passing off action is that A is not entitled to represent his goods as the goods of B but it is not necessary for B

to prove that a did this knowingly or with any intent to deceive. It is enough that the get-up of B's goods has

become distinctive of them and that there is a probability of confusion between them and the goods of A. No

case of actual deception not any actual damage need by proved. At common law the action was not

maintainable unless there had been fraud on A's part. In equity, however, Lord Cottenham L.C. in Millington

v. Fox ((1833)3 My & Cr. 388), held that it was immaterial whether the defendants had been fraudulent or notin using the plaintiff's trade mark and granted an injunction accordingly. The common law courts, however,

adhered to their view that fraud was necessary until the Judicature Acts, by fusing law and equity, gave the

equitable rule the victory over the common law rule.

7. The two actions, however, are closely similar in some respects. As was observed by the Master of the Rolls

in Saville Perfumery Ltd. v. June Perfect Ltd. ((1941)58 RPC 147 (161)).

"The Statute law relating to infringement of trade marks is based on the same fundamental idea as the law

relating to passing off. But it differs from that law in two particulars, namely (1) it is concerned only with one

method of passing-off, namely, the use of a trade mark, and (2) the statutory protection is absolute in the sense

that once a mark is shown to offend the user of it cannot escape by showing that by something outside theactual mark itself he has distinguished his goods from those of the registered proprietor. Accordingly, in

considering the question of infringement the courts have held, and it is now expressly provided by the Trade

Marks Act, 1938, Section 4, that infringement takes place not merely by exact imitation but by the use of a

mark so nearly resembling the registered mark as to be likely to deceive." In an action for infringement where

the defendant's trade mark is identical with the plaintiff's mark the Court will not inquire whether the

infringement is such as is likely to deceive or cause confusion. But where the alleged infringement consists of 

using not the exact mark on the Register, but something similar to it the test of infringement is the same as in

an action for passing-off. In other words, the test as to likelihood of confusion or deception arising from

similarity of marks is the same both in infringement and passing-off actions."

17. Delhi High Court in Hindustan Pencils Pvt. Ltd. v. M/s. India Stationary Products Co. and another (supra),

has considered at length the question of delay and has held that delay will not defeat statutory rights. The

relevant observations are as under :

"31. Even though there may be some doubt as to whether laches or acquiescence can deny the relief of a

permanent injunction, judicial opinion has been consistent in holding that if the defendant acts fraudulently

with the knowledge that he is violating the plaintiffs rights then in that case, even if there is an inordinate

delay on the part of the plaintiffs in taking action against the defendant, the relief of injunction is not denied.

The defence of laches or inordinate delay is a defence in equity. In equity both the parties must come to Court

with clean hands. An equitable defence can be put up by a party who has acted fairly and honestly. A person

who is guilty of violating the law or infringing or usurping somebody else's right cannot claim the continued

misuse of the usurped right. It was observed by Romer J. in the matter of an application brought by J. R.

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 7

Page 8: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 8/11

Parkington and Co. Ltd. (1946)63 RPC 171, at page 181 that "in my judgment, the circumstance which attend

the adoption of a trade mark in the first instance are of considerable importance when one comes to consider

whether the use of that mark has or has not been a honest user. If the user in its inception was tainted it would

be difficult in most cases to purify it subsequently". It was further noted by the learned Judge in that case that

he could not regard the discreditable origin of the user as cleansed by the subsequent history. In other words,

the equitable relief will be afforded only to that party who is not guilty of a fraud and whose conduct shows

that there had been, on his part, an honest concurrent user of the mark in question. If a party, for no apparent

or a valid reason, adopts, with or without modifications, a mark belonging to another, whether registered ornot, it will be difficult for that party to avoid an order of injunction because the court may rightly assume that

such adoption of the mark by the party was not an honest one. The Court would be justified in concluding that

the defendant, in such an action, wanted to cash in on the plaintiffs name and reputation and that was the sole,

primary or the real motive of the defendant adopting such a mark. Even if, in such a case, there may be an

inordinate delay on the part of the plaintiff in bringing a suit for injunction, the application of the plaintiff for

an interim injunction cannot be dismissed on the ground that the defendant has been using the mark for a

number of years. Dealing with this aspect Harry D. Nims in his "The Law of Unfair Competition and Trade

Marks", Fourth Edition, Volume Two at page 1282 noted as follows :

"Where infringement is deliberate and wilful and the defendant acts fraudulent with knowledge that he is

violating plaintiffs rights, essential elements of estoppel are lacking and in such a case the protection of plaintiff's right by injunctive relief never is properly denied. "The doctrine of estoppel can only be invoked to

promote fair dealings."

32. It would appear to me that where there is an honest concurrent use by the defendant then inordinate delay

laches may defeat the claim of damages or rendition of accounts but the relief of injunction should not be

refused. This is so because it is the interest of the general public, which is the third party in such cases, which

has to be kept in mind. In the case of inordinate delay or laches, as distinguished from the case of an

acquiescence, the main prejudice which may be caused to the defendant is that by reason of the plaintiff not

acting at an earlier point of time the defendant has been able to establish his business by using the infringing

mark. Inordinate delay or laches may be there because the plaintiff may not be aware of the infringement by

the defendant or the plaintiff may consider such infringement by the defendant as not being serious enough tohurt the plaintiff's business. Nevertheless, if the court comes to the conclusion that prejudice is likely to be

caused to the general public who may be misled into buying the goods manufactured by the defendant

thinking them to be the goods of the plaintiff then an appropriate cases, allow some time to the defendants to

sell off their existing stock but an injunction should but denied.

33. Where the plaintiff however, is guilty of acquiescence, the different considerations may apply. As already

noted, acquiescence may mean an encouragement by the plaintiff to the defendant to use the infringing mark.

It is as if the plaintiff wants the defendant to be under the belief that the plaintiff does not regard the action of 

the defendant as being violative of the plaintiffs rights. Furthermore, there should be a tacit or an express

assent by the plaintiff to the defendant's using the mark and in a way encouraging the defendants to continue

with the business. In such a case the infringer acts upon an honest mistaken belief that he is not infringing the

trade mark of the plaintiff and if, after a period of time when the infringer has established the business

reputation, the plaintiff turns around and brings an action for injunction, the defendant would be entitled to

raise the defence of acquiescence. Acquiescence may be a good defence even to the grant of a permanent

injunction because the defendant may legitimately contend that the encouragement of the plaintiff to the

defendant's use of the mark in effect amounted to the abandonment by the plaintiff of his right in favour of he

defendant and over a period of time, the general public has accepted the goods of the defendant resulting in

increase of its sale. It may, however, be in stated that it will be for the defendant in such cases to prove

acquiescence by the plaintiff, Acquiescence cannot be inferred merely by reason of the fact that the plaintiff 

has not taken any action against the infringement of its right."

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 8

Page 9: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 9/11

18. Decision of the Delhi High Court is quoted with approval by this court in case of Schering Corporation

and others v. Kilitch Co. (Pharma) Pvt. Ltd. ((1994) IPLR 1). This Court agreed with the law laid down by the

Delhi High Court. Relevant observations are as under :

"The principles enunciated by the single Judge of the Delhi High Court, in our opinion, are a complete answer

to the Defendants' plea on the ground of delay. Once it is established that there is visual and phonetic

similarity, and once it is established that the Defendant's adoption of the trade mark is not honest or genuine,

then the consideration of any plea as to delay must be on the basis of a consideration whether there has beensuch delay in the matter as has led the Defendants to assume that the plaintiffs have given up their contention

and/or whereby the Defendants have altered their position so that it would be inequitable to grant interim

relief to stop them from using the trade mark until the suit is decided ?"

19. Division Bench of this Court in case of National Chemicals & Colour Co. and others v. Reckitt & Colman

of India Limited and another (supra), in para 22 has observed as under :

"21. The learned single Judge has also negatived any honest, concurrent use of the trade mark proposed to be

registered by the appellants which would entitle the Registrar to grant registration to this trade mark under

Section 12(3) of the Trade and Merchandise Marks Act 1958. In 1971, when the appellants first applied for

registration of their trade mark, they applied for registration, both of the picture marks as also of the word"Bul Bul". It was, however, pointed out to them by the Registrar of Trade Marks that there were other

registered trade marks which contained the picture of a bird on a twig. As a result, the appellants dropped the

device of the two birds on a twig and merely applied for registration of the word mark "Bul Bul", which

registration was granted. It seems that thereafter they continued to use the picture mark for a couple of years.

Once again they applied for registration of the picture mark in 1973. The learned single Judge has rightly held

that this cannot be considered as an honest concurrent user. The appellants were aware that there were other

similar registered trade marks. Nevertheless they continued to use the same device on their product

presumably in the hope of getting registration at a subsequent date. Such a user cannot be considered as an

honest concurrent user under Section 12(3). We therefore agree with the learned single Judge that the benefit

of Section 12(3) cannot be granted to the appellants."

20. In view of the law down by the Apex Court, this court and Delhi High Court, plaintiff cannot be

non-suited on ground of delay or laches. On the ground of acquiescence, there is nothing on record to show

that any time plaintiffs acquiesced with defendants marketing its product under the name PANADOL.

Defendants have placed reliance upon the decision of Madhya Pradesh High Court in case of M/s.

Radhakishan Naraindas v. Trilokchand and others (supra). Relevant observations are as follows :

"(3) Before us the question has arisen whether Section 25 comes to protect the defendants in their user of the

label 'Gilhari Chhap'. The provisions of that section are as follows :

'Nothing' in this Act, shall entitle the proprietor or a registered user of a trade mark to interfere with or restrain

the use by any person of a trade mark identical with or nearly resembling it in relation to goods in relation to

which that person or a predecessor in title of his has continuously used that trade mark from a date prior :

(a) *** *** *** ***

(b) to the registration of the first-mentioned trade mark in respect of those goods in the name of the proprietor

or a predecessor in title of his, Whichever is the earlier, or to object (on such use being proved) to registration

of that identical or nearly resembling trade mark in respect of those goods under sub-section (2) of Section 10.

The Learned counsel for the appellant contends on the authority of two cases reported in Reinhardt v.

Scalding, and Subbiah v. Kumarval Nadar, that a mere declaration in respect of a label before a Justice of the

Peace in the year 1936 was not sufficient to discharge the burden laid by Section 25 upon a defendant who

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 9

Page 10: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 10/11

wished to set up prior user of a lable."

"(5) There can be no doubt that if the label was in current use before the registration of the plaintiff's label

under the India Trade Mark Act, the provisions of the section above quoted would have prima facie the

defendant from the grant of a temporary injunction. For this purpose, however, there has to be evidence.

Unfortunately, neither side cared to lead evidence and relied upon affidavits, which in the circumstances of 

the case were a poor substitute for the kind of proof needed to apply Section 25 of the Indian Trade Marks Act

to such a case. Before use also reliance was placed upon those same affidavits and the declaration to which wehave referred. We do not think that in view of the dicta in the two cases cited, particularly the dicta of their

Lordships of the Privy Council, we can look into this kind of evidence to decide upon the application of 

Section 25 of the Act. Since there is no material before us, we are unable to give a finding whether in the

circumstances of the case a temporary injunction ought or ought not to issue. Equally, the trial Court was not

in a position to give such a finding either, whether affirmatively or negatively. The proper course for the

subordinate Court was therefore, to call for prima facie evidence of user or non-user and to decide summarily

the question of a grant of temporary injunction in the light of such evidence."

and decision of Delhi High Court dated 10-7-1991 in Hindustan Pencils Ltd. v. Aptudet Industries, (supra).

"7. Coming to the second and third contentions of the defendants, taking into account the various facts andalso the documents placed on record by both the parties. I find that the defendants have been using the trade

mark NATRAJ as also the device of NATRAJ prior to 1983 and even to the knowledge of the plaintiff since

1986. Such use of marks by the defendants prima facie appears to have been open and honest since before

1975 and that their products are different from those of the plaintiff who is admittedly not producing or selling

either sealing wax or the chalks sticks or colouring chalks. These facts coupled with the fact that the plaintiff 

had taken no steps to enforce any right that it may be having against the defendants for about 5 years has

given rise to certain equities in favour of the defendants. It is true that in a number of cases it has been

repeatedly held that in an action for infringement of trade mark, delay in initiating an action for infringement

is not fatal and that the statutory protection should not be lightly denied to the registered proprietor and that if 

there is some delay the exclusive right of user cannot be lost by delay alone. Such would be the case in the

absence of the circumstances and provision of law referred to hereafter.

By placing reliance on these authorities, defendants contend that their act is protected under Section 33 of the

Act. However, in view of the decision referred-to above by the plaintiff, defendants' case cannot be accepted.

21. Defendants' further reliance upon decision of this Court in case of Consolidated Foods Corporation v.

Bandon & Co. Pvt. Ltd. (supra), wherein it is observed as under :

"A trader acquires a right of property in a distinctive mark merely by using it upon or in connection with his

goods irrespective of the length of such user and the extent of his trade. The trader who adopts such a mark is

entitled to protection directly the article having assumed a vendible character is launched upon the market. As

between two competitors who are each desirous of adopting such mark it is entirely a question of who gets

there first. To claim the proprietorship of a mark it is not necessary that the goods should have acquired a

reputation for quality under that mark. Actual use of the mark under such circumstances as showing an

intention to adopt and use it as a trade mark is the test rather than the extent or duration of the use. A mere

casual intermittent or experimental use may be insufficient to show an intention to adopt the mark as a trade

mark for specific articles of goods. Registration under the statute does not confer any new right to the mark 

claimed or any greater rights than what already existed at common law and at equity without registration. It

facilitates a remedy which may be enforced and obtained throughout the State and it establishes the record of 

facts affecting the right to the mark. Registration itself does not create a trade mark. The trade mark exists

independently of the registration which merely affords further protection under the statute. Common law

rights are left wholly unaffected. Priority in adoption and use of a trade mark is superior to priority in

registration."

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 10

Page 11: Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

7/27/2019 Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

http://slidepdf.com/reader/full/winthrop-products-inc-vs-eupharma-laboratories-ltd-on-2-september-1997 11/11

This decision is of not much assistance to defendants as in view of the decision referred to above as the user

of dishonest user defendant will not be entitled for protection.

22. Defendants' argument that as the product is not marketed in India, the plaintiffs will not be entitled for

injunction and reliance placed on decision of Calcutta High Court dated 27th/28th September, 1993 in

Kabhushiki Kaiha Toshiba (Toshiba Corporation) v. Toshiba Appliances Co. and others cannot be accepted.

Said decision on facts is not applicable to the present case. Even otherwise, in view of the decision of this

Court as referred to above, defendants cannot be permitted to use word PANADOL to market its product.

23. Defendants' case that registration is not valid as rectification proceedings are pending and its reliance upon

decision of 1986/87 I.P.L.R. 180 is not of much assistance to defendants in view of direct decision of this

Court in case of Poddar Tyres Ltd. v. Bedrock Sales Corporation Ltd. and another (supra), wherein it has been

held as under :

"41. Mr. Rahimtoola then contended that Santosh Kumar Poddar has filed an application with the Registrar, in

his capacity as a shareholder of the second defendants, for holding that the plaintiffs are not entitled to be the

registered proprietors of the trade mark, as the assignment of the proprietary rights in the said trade mark by

the second defendants to the plaintiffs is invalid. Whatever the worth of the said application, it is not possible

to accept the contention that such an application can prevent the registered proprietor from asserting his rightsas registered proprietor of the trade mark continues on the register. The short answer to the contention is

contained in the judgment of Justice Vimadalal of this Court in Hindustan Embroidery Mills Pvt. Ltd. v. K.

Ravindra & Co. (supra), wherein the learned Judge pointed out that it is not the practice of this Court to

consider the validity of the registration of a trade mark on a motion for interlocutory injunction taken out by

the person who has got the mark registered in his name. While a mark remains on the register (even wrongly),

it is not desirable that others should imitate it. I am unable to accept the contention that the pendency of the

rectification application prevents the plaintiffs from exercising the statutory rights under the Trade Marks Act

or from seeking interim reliefs based thereupon. Application for rectification or removal is not of much

assistance to defendant as position stands today in law plaintiffs are proprietor of registered trade mark 

PANADOL and defendants cannot be permitted to use the same.

24. In view of the aforesaid findings, it must be held that defendants have no vested right to use trade name

PANADOL, plaintiffs are registered proprietors, its registration is valid, the adoption of name PANADOL by

defendant in 1972 is not in good faith, user from 1972 will not give any right to defendants to claim said name

as proprietor and plaintiff cannot be non-suited on the ground of delay or acquiescence. In my judgment, in

view of the findings recorded in plaintiffs' favour and law as stand today, defendants will have to be prevented

from using the trade mark or name PANADOL as it infringes plaintiffs' rights as plaintiffs are only entitled to

use the trade mark PANADOL. Similarly defendants will have to be prohibited from passing off defendants'

product by using trade mark PANADOL even under Common Law.

25. In the result, defendant, its servants, officers, agents, assignee, and successors in title are prevented by

order of injunction -

(1) from using in any form or manner whatsoever the trade mark or name PANADOL,

(2) from passing off or attempting to pass off defendants' product in the name PANADOL or advertising it in

any manner or in any form the PANADOL as its products.

26. Motion made absolute in the aforesaid terms with cost quantified at Rs. 5,000/-.

27. At the question of defendant, operation of this order is stayed for a period of 6 weeks from today.

28. Certified copy is expedited.

Winthrop Products Inc. vs Eupharma Laboratories Ltd. on 2 September, 1997

Indian Kanoon - http://indiankanoon.org/doc/774606/ 11